Calcific Aortic Valve Disease

Calcific Aortic Valve Disease (CAVD) is a progressive condition characterized by the accumulation of calcium deposits on the aortic valve leaflets. This common heart valve disorder primarily affects the elderly population but can also occur in younger individuals with certain risk factors. Over time, the calcium buildup leads to the thickening and stiffening of the valve, impairing its ability to open and close properly. As CAVD advances, it may result in symptoms such as chest pain, shortness of breath, and fatigue. The underlying causes of CAVD are multifactorial, involving a combination of genetic predisposition, age-related degeneration, and various cardiovascular risk factors. Early detection through diagnostic imaging, such as echocardiography, plays a crucial role in managing CAVD. Treatment options range from lifestyle modifications and medications to surgical interventions, with the goal of alleviating symptoms and improving overall heart function. Ongoing research in the field aims to enhance our understanding of CAVD mechanisms, paving the way for innovative therapeutic approaches and preventive strategies. As CAVD poses a significant health challenge globally, raising awareness about risk factors and promoting early intervention is essential for improving patient outcomes and reducing the burden of this prevalent cardiovascular condition